As of Tuesday, December 16, Alto Neuroscience, Inc.’s ANRO share price has dipped by 6.34%, which has investors questioning ...

These deals radically reshaped the biopharma world, either by one vaccine rival absorbing another, a Big Pharma doubling down ...

Zachary Contreras highlighted strategies discussed at AMCP Nexus for improving timely access to monoclonal migraine receptor ...

Flow Neuroscience has secured FDA approval for its at-home brain stimulation device, the FL-100 wearable device, as a ...

Propelled by a flurry of dealmaking late in the year, 2025 M&A ended on a strong note, with high activity expected to ...

Nexstim’s Therapy Business markets and sells the NBS System 6 which is FDA-cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States.

Detailed price information for SPDR S&P Midcap International (MDD-A) from The Globe and Mail including charting and trades.

Detailed price information for SPDR S&P Midcap International (MDD-A) from The Globe and Mail including charting and trades.

Neurocrine Biosciences, Inc. ( NBIX) Discusses Progress and Strategy in Neurology and Obesity R&D Programs December 16, 2025 12:00 PM EST ...

The Bombay High Court on Thursday disposed of a petition filed in December 2021 by the next of kin of Father Stan Swamy, who ...

Discusses Latest Phase III Updates for Azetukalner in Epilepsy and Commercial Launch Preparation December 10, 2025 ...

More than 600 items stolen from a city museum are irreplaceable, an academic has said. Simon Potter, professor of modern ...